Showing 1 - 6 results of 6 for search '"human liver"', query time: 0.07s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    In Vitro Models for the Study of Liver Biology and Diseases: Advances and LimitationsSummary by Savneet Kaur, Srivatsan Kidambi, Martí Ortega-Ribera, Le Thi Thanh Thuy, Natalia Nieto, Victoria C. Cogger, Wei-Fen Xie, Frank Tacke, Jordi Gracia-Sancho

    Published 2023-01-01
    “…Based on cell lines, induced pluripotent stem cells or primary cells derived from mouse or human liver as well as whole tissue (slices), such in vitro single- and multicellular models, including complex microfluidic organ-on-a-chip systems, provide tools to functionally understand mechanisms of liver health and disease. …”
    Get full text
    Article
  5. 5

    Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma by Qingquan Bai, Qingquan Bai, Runyang Li, Xiao He, Xiaoting Hong, Ying Yan, Zhengyang Zhao, Han Lin, Frank Tacke, Cornelius Engelmann, Cornelius Engelmann, Cornelius Engelmann, Tianhui Hu, Tianhui Hu

    Published 2023-12-01
    “…However, their functions at different disease stages are not fully understood.MethodsIn this study, we used single-cell RNA sequencing (scRNA-seq) to characterize the human liver immune microenvironment at different disease stages. …”
    Get full text
    Article
  6. 6

    Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers by Cornelius Engelmann, Martina Sterneck, Karl Heinz Weiss, Silke Templin, Steffen Zopf, Gerald Denk, Dennis Eurich, Johann Pratschke, Johannes Weiss, Felix Braun, Martin-Walter Welker, Tim Zimmermann, Petra Knipper, Dirk Nierhoff, Thomas Lorf, Elmar Jäckel, Hans-Michael Hau, Tung Yu Tsui, Aristoteles Perrakis, Hans-Jürgen Schlitt, Kerstin Herzer, Frank Tacke

    Published 2020-07-01
    “…Human cytomegalovirus (CMV) remains a major cause of mortality and morbidity in human liver transplant recipients. Anti-CMV therapeutics can be used to prevent or treat CMV in liver transplant recipients, but their toxicity needs to be balanced against the benefits. …”
    Get full text
    Article